Phase 3 Study of MAP0004 in Adult Migraineurs
Completed · Phase 3 · Has a placebo group
Conditions studied: Migraine Disorders
In brief
This is a randomized, double blind, placebo controlled, parallel group study of MAP0004 in adult migraineurs. Subjects will self administer study drug in the outpatient setting.
Key facts
- Study ID
- NCT00623636
- Run by
- Allergan
- People needed
- 902
- Starts
- 2008-07-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2014-01-09
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Swedish Pain and Headache Clinic — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.